Furniture Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Furniture Press Releases.

Press releases published on April 17, 2026

HYTN Introduces HARd Remediation to GMP Processing Services, Releases Product in Germany
Boundless Bio Presents Preclinical Breast Cancer Data from its Oral Kinesin Degrader Program at 2026 AACR Annual Meeting
RPX Gold Announces Upsize of Previously Announced “Best Efforts” LIFE Offering and Private Placement to C$12,300,000
CAPHRA: Making NRTs Harder to Get is Public Health Madness
Celularity Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing
Tree Island Steel Provides Update on Annual General Meeting of Shareholders
Top Pendant Light Manufacturers Leading Innovation in Modern Lighting Design
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BGIN BLOCKCHAIN LIMITED Schedules the Fiscal Year 2025 Earnings and Conference Call on April 24, 2026
Sonoco To Report First Quarter 2026 Results
TTEC Schedules First Quarter 2026 Earnings Release and Webcast of Investor Conference Call
ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules
Theriva™ Biologics Announces Upcoming Presentation of Additional Data from the VIRAGE Phase 2b Clinical Trial of VCN-01 in Metastatic Pancreatic Cancer at AACR 2026 Annual Meeting
4DMT Announces New Employment Inducement Grants
CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SEALSQ Announces Agenda of its 2026 Annual General Meeting of Shareholders
ORIC® Pharmaceuticals Presents Preclinical Data to Support the Potential of Rinzimetostat Across Prostate Cancer and in Emerging Resistance Settings at the 2026 American Association for Cancer Research (AACR) Annual Meeting
Pyxis Oncology to Present New Preclinical Data Showing Synergistic Anti-Tumor Activity in a HNSCC model with maMICVO in Combination with Anti-PD-1 at AACR 2026
Revolution Medicines Announces Closing of Concurrent Upsized Public Offerings with Aggregate Gross Proceeds of Approximately $2.2 Billion, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Adagene Presents Two Posters at AACR 2026 with New Data Highlighting Muzastotug’s Potential as a Backbone Combination Therapy for Multiple Tumor Types

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Furniture Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.